143 related articles for article (PubMed ID: 20534400)
1. Expression of EGFR, HER-2/neu and KIT in germ cell tumours.
Durán I; García-Velasco A; Ballestín C; García E; Martínez-Tello F; Pond GR; García-Carbonero R; Cortés-Funés H; Paz-Ares L
Clin Transl Oncol; 2010 Jun; 12(6):443-9. PubMed ID: 20534400
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
[TBL] [Abstract][Full Text] [Related]
3. Expression of HER-2/neu in testicular tumors.
Mandoky L; Geczi L; Bodrogi I; Toth J; Bak M
Anticancer Res; 2003; 23(4):3447-51. PubMed ID: 12926088
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
5. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.
Wang X; Jones TD; Zhang S; Eble JN; Bostwick DG; Qian J; Lopez-Beltran A; Montironi R; Harris JJ; Cheng L
Mod Pathol; 2007 Feb; 20(2):175-82. PubMed ID: 17192792
[TBL] [Abstract][Full Text] [Related]
6. Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors.
Madani A; Kemmer K; Sweeney C; Corless C; Ulbright T; Heinrich M; Einhorn L
Ann Oncol; 2003 Jun; 14(6):873-80. PubMed ID: 12796025
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the c-kit proto-oncogene in germ cell tumours.
Izquierdo MA; Van der Valk P; Van Ark-Otte J; Rubio G; Germa-Lluch JR; Ueda R; Scheper RJ; Takahashi T; Giaccone G
J Pathol; 1995 Nov; 177(3):253-8. PubMed ID: 8551387
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu expression in germ cell tumours.
Soule S; Baldridge L; Kirkpatrick K; Cheng L; Gilbert JL; Smith LR; Thurston VC; Vance GH; Einhorn L; Miller K
J Clin Pathol; 2002 Sep; 55(9):656-8. PubMed ID: 12194993
[TBL] [Abstract][Full Text] [Related]
9. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis JW; Looijenga LH; Bokemeyer C
Cancer; 2002 Jul; 95(2):301-8. PubMed ID: 12124830
[TBL] [Abstract][Full Text] [Related]
10. Growth regulatory factors and signalling proteins in testicular germ cell tumours.
Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M
APMIS; 2003 Jan; 111(1):212-24; discussion 224. PubMed ID: 12752264
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CD117 in human testicular germ cell tumors and its diagnostic value for seminoma and nonseminoma].
Liu DL; Lu YP; Shi HY; Zhu SX; Lü JW; Li WF; Rong X
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):38-41. PubMed ID: 18297810
[TBL] [Abstract][Full Text] [Related]
12. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract][Full Text] [Related]
14. Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases.
Pfister D; Richter S; Thüer D; Giedl J; Heidenreich A; Klotz T
Urology; 2010 Nov; 76(5):1266.e6-9. PubMed ID: 21056276
[TBL] [Abstract][Full Text] [Related]
15. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma.
Brunner M; Thurnher D; Pammer J; Geleff S; Heiduschka G; Reinisch CM; Petzelbauer P; Erovic BM
Mod Pathol; 2008 Jul; 21(7):876-84. PubMed ID: 18408656
[TBL] [Abstract][Full Text] [Related]
16. Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors.
Sadigh S; Farahani SJ; Shah A; Vaughn D; Lal P
Am J Clin Pathol; 2020 Feb; 153(3):387-395. PubMed ID: 31802108
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of HER-2/neu overexpression in patients with testicular nonseminomatous germ cell tumor.
Ghavamnasiri MR; Saeedi Saedi H; Shahid Sales S; Ghafarzadegan K
Urol J; 2010; 7(1):26-9. PubMed ID: 20209452
[TBL] [Abstract][Full Text] [Related]
18. Germ cells positive for PLAP and c-Kit in 11-16 year old normal boys with ongoing spermatogenesis.
Kvist K; Hildorf S; Clasen-Linde E; Cortes D; Thorup J
Pediatr Surg Int; 2020 Oct; 36(10):1249-1254. PubMed ID: 32772137
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
20. Biological markers of cisplatin resistance in advanced testicular germ cell tumours.
García-Velasco A; Durán I; García E; Tarón M; Ballestín C; Castellanos D; Cortés-Funés H; Paz-Ares L
Clin Transl Oncol; 2012 Jun; 14(6):452-7. PubMed ID: 22634534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
